Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2012
Is isolated systolic hypertension worse than combined systolic/diastolic hypertension?Yonggang Ma, Andriy Yabluchanskiy, Merry L Lindsey, et al.
Health Policy and Planning|April 2, 2016
Use of traditional medicine in middle-income countries: a WHO-SAGE studyOyinlola Oyebode, Ngianga-Bakwin Kandala, Peter J Chilton, et al.
American Journal of Public Health|February 18, 2015
Defining the functions of public health governanceValeria Carlson, Marita J Chilton, Liza C Corso, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 15, 2005
Cardioprotection: the role of beta-blocker therapyBrent M Egan, Jan Basile, Robert J Chilton, et al.
Cardiovascular Endocrinology & Metabolism|April 18, 2025
Impact of insulin resistance and microvascular ischemia on myocardial energy metabolism and cardiovascular function: pathophysiology and therapeutic approachesAriana Y Ramirez, Elizabeth R Doman, Kevin Sanchez, et al.
JACC. Case Reports|October 3, 2025
Hypereosinophilic Syndrome Presenting as Coronary Artery Spasm and ST-Segment Elevation Myocardial InfarctionMatthew P Czaja, Yogamaya Mantha, Mark L Canales, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 5, 2018
Changes in Heart Rate Associated with Exenatide Once Weekly: Pooled Analysis of Clinical Data in Patients with Type 2 DiabetesSteven P Marso, Elise Hardy, Jenny Han, et al.
Bulletin of the World Health Organization|January 2, 2015
Peri-operative pulse oximetry in low-income countries: a cost-effectiveness analysisSamantha L Burn, Peter J Chilton, Atul A Gawande, et al.
Plos One|June 12, 2012
Bayesian cohort and cross-sectional analyses of the PINCER trial: a pharmacist-led intervention to reduce medication errors in primary careKarla Hemming, Peter J Chilton, Richard J Lilford, et al.
European Endocrinology|June 7, 2018
Glucose Control and Cardiovascular Outcomes in Clinical Trials of Sodium Glucose Co-transporter 2 Inhibitor Treatments in Type 2 DiabetesRene A Oliveros, Son V Pham, Steven R Bailey, et al.
Pageof 8